Print
Email
Innodata Isogen Inc (INOD) filed Quarterly Report for the period ended 2011-09-30.
Innodata Isogen Inc has a market cap of $91.5 million; its shares were traded at around $3.68 with a P/E ratio of 26.3 and P/S ratio of 1.5.
This is the annual revenues and earnings per share of INOD over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of INOD.
Highlight of Business Operations:
2525
In June 2011, the Financial Accounting Standard Board (FASB) issued a standard regarding the presentation of other comprehensive income (OCI). The new guidance eliminate the option of presenting OCI in the statement of changes in equity, and requires to report items of OCI in either (1) a continuous statement of comprehensive income or (2) two separate but consecutive statements. The guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. We will adopt the guidance as required. The adoption of this guidance is not expected to have any impact on our condensed consolidated financial statements.
In September 2011, the FASB issued an update on the testing of goodwill impairment. The revised standard provides companies with the option of performing a “qualitative” assessment to determine whether further impairment testing is necessary. An entity can choose to perform the qualitative assessment on none, some, or all of its reporting units or can bypass the qualitative assessment for any reporting unit in any period and proceed directly to step one of the impairment test. The standard is effective for fiscal years beginning after December 15, 2011, however early adoption is permitted. We adopted the guidance early and performed a qualitative assessment. The adoption of this guidance did not have any impact on our condensed consolidated financial statements.
Subscribe RSS
